Global Antibiotic Research and Development Partnership (Gardp)

GARDP is a not-for-profit focused on developing treatments for drug-resistant infections.

🤖

AI Overview

With $60K in lobbying spend across 4 quarterly filings, Global Antibiotic Research and Development Partnership (Gardp) is an active lobbying client. Their lobbying covers 2 issue areas.

$60K
Total Spend
1
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$60K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Budget/Appropriations

  • Drug resistance and antibiotic development.
  • FY22 appropriations regarding antibiotic research and development.
  • Antimicrobial resistance; antibiotic research and development.
  • FY 2022 appropriations regarding antibiotic research and development.
  • Antimicrobial resistance; Antibiotic research and development; Pandemic preparedness as it relates to antimicrobial resistance; S. 2076, H.R. 3932 - PASTEUR Act; H.R. 2036 - Saving Us from Pandemic Er

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.